The first genome-wide association study performed in a UK coeliac disease (CD) case-control cohort revealed association with a linkage disequilibrium block containing the KIAA1109/Tenr/IL2/IL21 genes. Also recently, an association with a nonsynonymous polymorphism in FcgRIIa (CD32a) was reported in CD with an unusually strong P-value. We aimed to replicate the reported associations with the single nucleotide polymorphisms rs13119723 A4G and rs6822844 G4T in the KIAA1109/Tenr/ IL2/IL21 region and rs1801274 G4A in the FcgRIIa gene in a family sample consisting of 325 Swedish/Norwegian families using the robust transmission disequilibrium test. The family sample used in this study included 100 families with two or more children affected by CD and 225 families with one affected child. We could confirm significant association between the polymorphisms rs13119723 A4G and rs6822844 G4T located in the KIAA1109/Tenr/IL2/IL21 region and CD (P-value 0.001 and 0.002, respectively). However, we found no association with the FcgRIIa rs1801274 G4A polymorphism (P-value ¼ 0.3). In conclusion, our results support the KIAA1109/Tenr/IL2/IL21 region as a true CD susceptibility region.
Introduction
Coeliac disease (CD) or gluten-sensitive enteropathy is a chronic inflammatory condition with autoimmune features, affecting the small intestine in genetically predisposed individuals. 1 HLA genes and non-HLA genes, together with gluten and most likely other environmental factors, are involved in disease development. Recently, the first genome-wide association analysis in CD revealed association with the KIAA1109/Tenr/IL2/IL21 gene region at chromosome 4q27 and was further confirmed in two independent case-control cohorts. 2 The genome-wide association study presented several associated single nucleotide polymorphisms (SNPs) in the 4q27 region all strongly significant (Po10
À10
). These SNPs map to a approximately 480 kb linkage disequilibrium (LD) block. This LD block was further subdivided into two blocks by finer haplotype analysis, of the UK cohort, of which rs13119723*G located in the hypothetical protein KIAA1109, was present on a single strongly associated haplotype in both blocks. In addition to CD, both type 1 diabetes and rheumatoid arthritis also demonstrated association with this region in another recent study. 3 In this study, the rs6822844*T showed a significantly decreased frequency in cases compared to controls and was present on the strongest associated haplotype in all the three diseases. rs6822844 is located in between interleukin 2 (IL2) and interleukin 21 (IL21). Both IL2 and IL21 are highly interesting candidate genes for CD susceptibility 4, 5 as both cytokines are T-cell derived and stimulate the T-cell activation and proliferation in an autocrine manner. IL2 promotes proliferation of T-cells, B-cells and NK-cells. Fina et al. 6 have recently shown that IL21 expression is enhanced in duodenal samples from untreated CD patients. Furthermore, neutralization of IL21 prevented gliadin driven T-b and interferon-g production in intestinal biopsies from CD patients.
Another recently proposed susceptibility gene for CD, also allegedly a common risk factor for autoimmune disease, is FcgRIIa (CD32a) located in chromosome region 1q23. 7 FcgRIIa is a low affinity activating Fcg receptor that binds immune complexes. Ligation of this Fc receptor leads to phagocytosis, dendritic cell maturation, increased stimulation of T cells and enhanced secretion of inflammatory cytokines. 8 FcgRIIa has two common alleles which differ by a histidine (H) to arginine (R) substitution at position 131 defined by the SNP rs1801274 G4A (also known as FcgRIIa*A519G). Compared to the R131 allotype, the H131 allotype (rs1801274*G) has higher avidity for complexed human IgG2 and IgG3. 9 Interestingly, individuals homozygous for rs1801274*G (H131) were associated with CD (odds ratio of 1.81, P ¼ 10
À6
), whereas weaker association were seen for type 1 diabetes and rheumatoid arthritis. 7 The unequivocal identification of IL2, IL21 and FcgRIIa as susceptibility genes in CD will have great implications for the understanding of the pathogenesis of this disease. The understanding of the molecular mechanisms of CD has made substantial advances in recent years, 10 and disease associated genes and gene variants can be readily tested in relevant disease models involving glutenreactive T-cell clones and disease specific anti-gluten and anti-transglutaminase antibodies. Apart from the implication for CD, this work may help in understanding how these genes are involved in other autoimmune diseases. There is, thus, an imminent need of replication of new, promising genetic findings of CD.
To our knowledge, only case-control studies have been performed to investigate associations with the KIAA1109/ Tenr/IL2/IL21 and the FcgRIIa gene in CD. In a casecontrol study design there is always a possibility of false positive associations due to population stratification and poorly matched controls. The present study aims at investigating if the relationship between the SNPs rs13119723 A4G, rs6822844 G4T and rs1801274 G4A and CD can be detected in the Swedish/Norwegian population using the robust transmission disequilibrium test (TDT).
Materials and methods

Subjects
This study included 325 nuclear CD families, 100 families with at least two affected siblings (multiplex families) and 225 trio-families (additional information about these families is available elsewhere). 11, 12 All affected family members strictly fulfilled the ESPGAN (European Society of Pediatric Gastroenterology and Nutrition) diagnostic criteria. 13 
Genotyping
The three candidate SNPs were genotyped using TaqMan technology and genotypes were generated by the SDS v 2.2. 1 software (Applied Biosystems, Foster City, CA, USA). At least two negative and three positive control samples (one of each genotype) were included in each PCR run, and additionally, 60 randomly selected samples were run in duplicate to score genotype error rate (estimated on the basis of the percentage of genotype calls deviating in the duplicates). Few individuals were not genotyped for some of the markers due to missing DNA.
Pedcheck was performed to reveal Mendelian inconsistencies.
Statistical analysis
Power for the three SNPs rs13119723, rs6822844 and rs1801274 was calculated using the TDT power calculator for discrete traits located at http://pngu.mgh. harvard. edu/~purcell/gpc using a one-sided test and significance level of 0.05. Genotype relative risks were obtained from the original publications.
2,7
Transmission disequilibrium test 14 analysis for SNPs as well as haplotypes was performed employing the GENEHUNTER v2.1 program. 15 A pure test for association with disease was performed with TDT using only the probands of the multiplex families (325 trio families). LD analysis between rs13119723 and rs6822844 was performed using Haploview version 3.32 (www.broad. mit.edu/mpg/haploview).
Results
Before our study, we estimated the power of our total family set (325 families). The power to confirm rs13119723, rs6822844 and rs1801274, given the same effect as seen in the original publications, was 77, 75 and 82%, respectively. The genotype success rate of rs13119723, rs6822844 and rs1801274 was 91, 96 and 97%, respectively, and no deviation was seen for the genotyping controls. The Pedcheck analysis revealed three inconsistencies for rs13119723 and one inconsistency for each of the markers rs6822844 and rs1801274. These pedigrees were removed from the analysis of the individual markers. When missing genotypes and Mendelian errors were taken into account, the remaining completely genotyped trios subjected to TDT analysis Abbreviations: CI, 95% confidence interval; OR, odds ratio; TDT, transmission disequilibrium test; T/NT, number of transmitted versus nontransmitted alleles; %T, the percentage of transmission. One member from each family was included in the analyses, resulting in a pure association test. P-values shown are uncorrected, one-sided and calculated using the binomial distribution.
IL2/IL21: susceptibility to coeliac disease S Adamovic et al were: rs1801274 (n ¼ 315), rs13119723 (n ¼ 249) and rs6822844 (n ¼ 279). When testing single markers using TDT, rs13119723*A and rs6822844*G were significantly over-transmitted to the affected children; that is, 66%; P-value ¼ 0.001 and 63%; P-value ¼ 0.002, respectively (Table 1) .
When combining the SNPs in a haplotype analysis, two haplotypes consisting of rs13119723*Ars6822844*G and rs13119723*G-rs6822844*T accounted for over 90 % of the observed haplotypes and the haplotype rs13119723*A-rs6822844*G was significantly over-transmitted to affected children (68%; P-value ¼ 0.0002) ( Table 1) . As seen in other populations, there was strong LD between rs13119723 and rs6822844, r 2 ¼ 0.90 in our Scandinavian population. The TDT analysis of the FcgRIIa polymorphism rs1801274 showed no association ( Table 1) .
Discussion
Several studies have pointed out region IL2/IL21 on chromosome 4q27 and FcgRIIa at 1q23 as susceptibility candidates in a number of autoimmune disorders with chronic inflammatory features. [16] [17] [18] [19] [20] Two recent publications, one by van Heel et al.
2 and one by Alizadeh et al., 7 reported association between CD and KIAA1109/Tenr/IL2/ IL21 and FcgRIIa, respectively. Both of these studies were based on a case-control approach, and one purpose of our study was to replicate the most associated SNPs from these publications in a family sample using TDT to avoid the possibility of a false positive finding due to population stratification. Our result confirms the association with the KIAA1109/Tenr/IL2/IL21 region but not with the FcgRIIa polymorphism. As mentioned earlier, the IL2/IL21 region has been implicated in several autoimmune diseases. 17, 18, 20 Moreover, many autoimmune disorders including type 1 diabetes are overrepresented in CD and vice versa. 21 Therefore, one would expect that within a similar ethnical population, CD and associated autoimmune diseases should demonstrate associations with the same alleles, and this seems to be the case in the KIAA1109/ Tenr/IL2/IL21 region. In type 1 diabetes, fine mapping and resequencing of the Tenr/IL2/IL21 has been performed in an effort to localize the causal variant. 22 No coding variants or obvious regulatory or splice variants were revealed, and the strong LD across the region restricted the fine-mapping to a 200-kb region.
We were unable to confirm association with the FcgRIIa*A519G polymorphism in our Scandinavian CD population. Several reasons could explain this lack of reproducibility, the most likely being no or insignificant contribution of FcgRIIa to the genetic predisposition to CD in our population. As our study, and others, was restricted to the investigation of the FcgRIIa*A519G polymorphism only, variable LD between FcgRIIa*A519G and a yet unidentified causative variant in the studied populations could possibly explain the discrepant results. It is also possible that the original finding was due to a false positive or an overestimated effect, implying insufficient power to detect it in our population.
We conclude that the chromosome region surrounding IL2/IL21 is a susceptibility region in CD. The region contains four genes; however, considering the involvement of IL2 and IL21 in inflammatory mechanisms and their modulating role in the immune response of the inflamed intestinal mucosa, they are very good candidates in which we should begin the search for functional variants directly influencing disease. Further work should define the role of these cytokines in the already existing pathogenic models of CD.
